GB8308235D0
(en)
*
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
US4597966A
(en)
*
|
1985-01-09 |
1986-07-01 |
Ortho Diagnostic Systems, Inc. |
Histidine stabilized immunoglobulin and method of preparation
|
DE3631229A1
(de)
*
|
1986-09-13 |
1988-03-24 |
Basf Ag |
Monoklonale antikoerper gegen humanen tumornekrosefaktor (tnf) und deren verwendung
|
US4877608A
(en)
*
|
1987-11-09 |
1989-10-31 |
Rorer Pharmaceutical Corporation |
Pharmaceutical plasma protein formulations in low ionic strength media
|
US4897465A
(en)
*
|
1988-10-12 |
1990-01-30 |
Abbott Laboratories |
Enrichment and concentration of proteins by ultrafiltration
|
US5811523A
(en)
*
|
1988-11-10 |
1998-09-22 |
Trinchieri; Giorgio |
Antibodies to natural killer stimulatory factor
|
US5530101A
(en)
*
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
JPH0791318B2
(ja)
|
1989-09-21 |
1995-10-04 |
三井東圧化学株式会社 |
蛋白質水溶液、蛋白質水溶液の濃度増大方法および蛋白質製剤
|
KR0185192B1
(ko)
*
|
1989-10-05 |
1999-04-01 |
제임스 더블유. 데이비 |
신규의 유전자 및 폴리펩티드의 무세포 합성 및 분리
|
US5780597A
(en)
*
|
1989-12-22 |
1998-07-14 |
Hoffmann-La Roche Inc. |
Monoclonal antibodies to cytotoxic lymphocyte maturation factor
|
US6713610B1
(en)
*
|
1990-01-12 |
2004-03-30 |
Raju Kucherlapati |
Human antibodies derived from immunized xenomice
|
US5945098A
(en)
*
|
1990-02-01 |
1999-08-31 |
Baxter International Inc. |
Stable intravenously-administrable immune globulin preparation
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
CA2109602C
(en)
|
1990-07-10 |
2002-10-01 |
Gregory P. Winter |
Methods for producing members of specific binding pairs
|
US5618710A
(en)
|
1990-08-03 |
1997-04-08 |
Vertex Pharmaceuticals, Inc. |
Crosslinked enzyme crystals
|
EP0564531B1
(en)
|
1990-12-03 |
1998-03-25 |
Genentech, Inc. |
Enrichment method for variant proteins with altered binding properties
|
WO1994004679A1
(en)
|
1991-06-14 |
1994-03-03 |
Genentech, Inc. |
Method for making humanized antibodies
|
GB9122820D0
(en)
*
|
1991-10-28 |
1991-12-11 |
Wellcome Found |
Stabilised antibodies
|
US5652138A
(en)
*
|
1992-09-30 |
1997-07-29 |
The Scripps Research Institute |
Human neutralizing monoclonal antibodies to human immunodeficiency virus
|
CA2125763C
(en)
*
|
1993-07-02 |
2007-08-28 |
Maurice Kent Gately |
P40 homodimer of interleukin-12
|
EP0638644A1
(en)
|
1993-07-19 |
1995-02-15 |
F. Hoffmann-La Roche Ag |
Receptors of interleukin-12 and antibodies
|
FR2708467B1
(fr)
|
1993-07-30 |
1995-10-20 |
Pasteur Merieux Serums Vacc |
Préparations d'immunoglobulines stabilisées et procédé pour leur préparation.
|
EP0659766A1
(en)
|
1993-11-23 |
1995-06-28 |
Schering-Plough |
Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
|
DE4344824C1
(de)
*
|
1993-12-28 |
1995-08-31 |
Immuno Ag |
Hochkonzentriertes Immunglobulin-Präparat und Verfahren zu seiner Herstellung
|
ZA95960B
(en)
|
1994-03-14 |
1995-10-10 |
Genetics Inst |
Use of interleukin-12 antagonists in the treatment of autoimmune diseases
|
US5910486A
(en)
*
|
1994-09-06 |
1999-06-08 |
Uab Research Foundation |
Methods for modulating protein function in cells using, intracellular antibody homologues
|
EP1978033A3
(en)
|
1995-04-27 |
2008-12-24 |
Amgen Fremont Inc. |
Human antibodies derived from immunized xenomice
|
US6267958B1
(en)
*
|
1995-07-27 |
2001-07-31 |
Genentech, Inc. |
Protein formulation
|
CN1151842C
(zh)
|
1995-07-27 |
2004-06-02 |
基因技术股份有限公司 |
稳定等渗的冻干蛋白制剂
|
US6685940B2
(en)
*
|
1995-07-27 |
2004-02-03 |
Genentech, Inc. |
Protein formulation
|
US5853697A
(en)
*
|
1995-10-25 |
1998-12-29 |
The United States Of America, As Represented By The Department Of Health & Human Services |
Methods of treating established colitis using antibodies against IL-12
|
US6297395B1
(en)
*
|
1995-11-10 |
2001-10-02 |
The Secretary Of State For Defence In Her Brittanic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland |
Calixarenes and their use for sequestration of metals
|
US6090382A
(en)
*
|
1996-02-09 |
2000-07-18 |
Basf Aktiengesellschaft |
Human antibodies that bind human TNFα
|
GB9610992D0
(en)
|
1996-05-24 |
1996-07-31 |
Glaxo Group Ltd |
Concentrated antibody preparation
|
AU7257696A
(en)
|
1996-10-11 |
1998-05-11 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Methods for enhancing oral tolerance and treating autoimmune disease using inhibitors of interleukin-12
|
ATE256476T1
(de)
|
1996-11-15 |
2004-01-15 |
Kennedy Inst Of Rheumatology |
Unterdrückung von tnfalpha und il-12 in der therapie
|
ES2301183T3
(es)
*
|
1996-12-03 |
2008-06-16 |
Amgen Fremont Inc. |
Anticuerpo completamente humano que se une al receptor del egfr.
|
BR9810409A
(pt)
|
1997-03-18 |
2000-08-22 |
Basf Ag |
Métodos e composições para a modulação de responsividade a corticosteróides
|
GB9705810D0
(en)
|
1997-03-20 |
1997-05-07 |
Common Services Agency |
Intravenous immune globulin
|
US6183744B1
(en)
|
1997-03-24 |
2001-02-06 |
Immunomedics, Inc. |
Immunotherapy of B-cell malignancies using anti-CD22 antibodies
|
AU6914998A
(en)
|
1997-04-07 |
1998-10-30 |
Cangene Corporation |
Intravenous immune globulin formulation containing a non-ionic surface active agent with improved pharmacokinetic properties
|
US6159468A
(en)
*
|
1997-04-28 |
2000-12-12 |
Eli Lilly And Company |
Activated protein C formulations
|
JP3919235B2
(ja)
|
1997-06-13 |
2007-05-23 |
ジェネンテク,インコーポレイテッド |
抗体製剤
|
US6171586B1
(en)
*
|
1997-06-13 |
2001-01-09 |
Genentech, Inc. |
Antibody formulation
|
AU9262598A
(en)
|
1997-08-18 |
1999-03-08 |
Innogenetics N.V. |
Interferon-gamma-binding molecules for treating septic shock, cachexia, immune diseases and skin disorders
|
EP0911037B2
(en)
*
|
1997-10-23 |
2007-06-13 |
Mitsubishi Pharma Corporation |
Room temperature storable immunoglobulin preparation for intravenous injection
|
EP0969867B1
(en)
|
1997-10-31 |
2004-09-01 |
Wyeth |
Use of anti-il-12 antibodies in transplantation rejection
|
TR200002145T2
(tr)
|
1998-01-23 |
2000-11-21 |
F.Hoffmann-La Roche Ag |
İnsan IL-12'ye karşı antikorlar
|
US20020161199A1
(en)
*
|
1998-04-08 |
2002-10-31 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
US6284282B1
(en)
*
|
1998-04-29 |
2001-09-04 |
Genentech, Inc. |
Method of spray freeze drying proteins for pharmaceutical administration
|
EP0953639A1
(en)
|
1998-04-30 |
1999-11-03 |
Boehringer Ingelheim International GmbH |
FAPalpha-specific antibody with improved producibility
|
AU1843200A
(en)
*
|
1998-12-09 |
2000-06-26 |
Protein Design Labs, Inc. |
Animal model for psoriasis for the prevention and treatment of psoriasis in humans
|
KR20140094647A
(ko)
|
1999-03-25 |
2014-07-30 |
아비에 도이치란트 게엠베하 운트 콤파니 카게 |
사람 il-12에 결합하는 사람 항체 및 이의 제조방법
|
US7883704B2
(en)
*
|
1999-03-25 |
2011-02-08 |
Abbott Gmbh & Co. Kg |
Methods for inhibiting the activity of the P40 subunit of human IL-12
|
US6914128B1
(en)
*
|
1999-03-25 |
2005-07-05 |
Abbott Gmbh & Co. Kg |
Human antibodies that bind human IL-12 and methods for producing
|
US20030148955A1
(en)
*
|
1999-04-19 |
2003-08-07 |
Pluenneke John D. |
Soluble tumor necrosis factor receptor treatment of medical disorders
|
AUPQ026799A0
(en)
|
1999-05-10 |
1999-06-03 |
Csl Limited |
Method of increasing protein stability by removing immunoglobulin aggregates
|
US7279146B2
(en)
*
|
2003-04-17 |
2007-10-09 |
Fluidigm Corporation |
Crystal growth devices and systems, and methods for using same
|
DE10022092A1
(de)
*
|
2000-05-08 |
2001-11-15 |
Aventis Behring Gmbh |
Stabilisiertes Protein-Präparat und Verfahren zu seiner Herstellung
|
EP1336410A4
(en)
*
|
2000-08-04 |
2005-10-12 |
Chugai Pharmaceutical Co Ltd |
PROTEIN INJECTION PREPARATIONS
|
TWI283182B
(en)
|
2000-08-07 |
2007-07-01 |
Nektar Therapeutics |
Inhalable spray dried 4-helix bundle protein powders having minimized aggregation
|
US6902734B2
(en)
*
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
JP5485489B2
(ja)
|
2000-08-11 |
2014-05-07 |
中外製薬株式会社 |
抗体含有安定化製剤
|
ES2332402T5
(es)
|
2000-10-12 |
2018-05-14 |
Genentech, Inc. |
Formulaciones de proteína concentradas de viscosidad reducida
|
WO2002043750A2
(en)
|
2000-12-01 |
2002-06-06 |
Battelle Memorial Institute |
Method for the stabilizing of biomolecules (e.g. insulin) in liquid formulations
|
US6693173B2
(en)
|
2000-12-26 |
2004-02-17 |
Alpha Therapeutic Corporation |
Method to remove citrate and aluminum from proteins
|
WO2002072636A2
(en)
*
|
2000-12-28 |
2002-09-19 |
Altus Biologics Inc. |
Crystals of whole antibodies and fragments thereof and methods for making and using them
|
EP1391209A4
(en)
*
|
2001-05-30 |
2009-12-16 |
Chugai Pharmaceutical Co Ltd |
PROTEIN PREPARATION
|
GB0113179D0
(en)
*
|
2001-05-31 |
2001-07-25 |
Novartis Ag |
Organic compounds
|
US6818613B2
(en)
|
2001-11-07 |
2004-11-16 |
Ortho-Mcneil Pharmaceutical, Inc. |
Aqueous sustained-release formulations of proteins
|
US20030143603A1
(en)
*
|
2001-11-30 |
2003-07-31 |
Jill Giles-Komar |
Anti-TNF antibodies, compositions, methods and uses
|
EP3578168A1
(en)
*
|
2002-02-14 |
2019-12-11 |
Chugai Seiyaku Kabushiki Kaisha |
Formulation of antibody-containing solutions comprising a sugar as a stabilizer
|
US7101576B2
(en)
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
US20040105889A1
(en)
*
|
2002-12-03 |
2004-06-03 |
Elan Pharma International Limited |
Low viscosity liquid dosage forms
|
CA2490423A1
(en)
|
2002-06-21 |
2003-12-31 |
Biogen Idec Inc. |
Buffered formulations for concentrating antibodies and methods of use thereof
|
WO2004007520A2
(en)
*
|
2002-07-12 |
2004-01-22 |
Medarex, Inc. |
Methods and compositions for preventing oxidative degradation of proteins
|
US20040126372A1
(en)
|
2002-07-19 |
2004-07-01 |
Abbott Biotechnology Ltd. |
Treatment of TNFalpha related disorders
|
US20040033228A1
(en)
|
2002-08-16 |
2004-02-19 |
Hans-Juergen Krause |
Formulation of human antibodies for treating TNF-alpha associated disorders
|
DK2261230T3
(en)
*
|
2002-09-11 |
2017-06-12 |
Chugai Pharmaceutical Co Ltd |
Method of Protein Purification.
|
US7674885B2
(en)
*
|
2002-11-01 |
2010-03-09 |
Bayer Healthcare Llc |
Process for concentration of macromolecules
|
US20040086532A1
(en)
*
|
2002-11-05 |
2004-05-06 |
Allergan, Inc., |
Botulinum toxin formulations for oral administration
|
WO2004055164A2
(en)
|
2002-12-13 |
2004-07-01 |
Abgenix, Inc. |
System and method for stabilizing antibodies with histidine
|
CN1745170A
(zh)
|
2002-12-17 |
2006-03-08 |
米迪缪尼疫苗股份有限公司 |
生物活性材料的高压喷雾干燥
|
AU2003291527A1
(en)
|
2002-12-31 |
2004-07-29 |
Nektar Therapeutics |
Antibody-containing particles and compositions
|
US7608260B2
(en)
*
|
2003-01-06 |
2009-10-27 |
Medimmune, Llc |
Stabilized immunoglobulins
|
JP2006516636A
(ja)
|
2003-01-30 |
2006-07-06 |
メディミューン,インコーポレーテッド |
抗インテグリンαvβ3抗体製剤及びその用途
|
SI2335725T1
(sl)
*
|
2003-04-04 |
2017-01-31 |
Genentech, Inc. |
Visokokoncentrirane formulacije protiteles in proteinov
|
WO2004102184A1
(en)
|
2003-05-09 |
2004-11-25 |
Arizeke Pharmaceuticals, Inc. |
Compositions and methods for concentrating polypeptides and proteins
|
ATE414106T1
(de)
*
|
2003-06-30 |
2008-11-15 |
Domantis Ltd |
Pegylierte single-domain-antikörper (dab)
|
ES2562912T5
(es)
*
|
2003-10-01 |
2020-02-18 |
Kyowa Hakko Kirin Co Ltd |
Procedimiento de estabilización de un anticuerpo y preparación de anticuerpo de tipo disolución estabilizada
|
JP4762717B2
(ja)
*
|
2003-10-09 |
2011-08-31 |
中外製薬株式会社 |
IgM高濃度安定化溶液
|
US7968684B2
(en)
*
|
2003-11-12 |
2011-06-28 |
Abbott Laboratories |
IL-18 binding proteins
|
EP1532983A1
(en)
*
|
2003-11-18 |
2005-05-25 |
ZLB Bioplasma AG |
Immunoglobulin preparations having increased stability
|
US20050159364A1
(en)
*
|
2003-12-19 |
2005-07-21 |
Cooper Garth J. |
Copper antagonist compounds
|
RU2390353C2
(ru)
*
|
2004-02-12 |
2010-05-27 |
Мерк Патент Гмбх |
Высококонцентрированные жидкие композиции анти-egfr антител
|
KR100486028B1
(ko)
|
2004-04-20 |
2005-05-03 |
주식회사 펩트론 |
단백질 함유 서방성 리피드 임플란트 및 이의 제조방법
|
US7727962B2
(en)
*
|
2004-05-10 |
2010-06-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Powder comprising new compositions of oligosaccharides and methods for their preparation
|
AR049390A1
(es)
|
2004-06-09 |
2006-07-26 |
Wyeth Corp |
Anticuerpos contra la interleuquina-13 humana y usos de los mismos
|
MX2007000891A
(es)
|
2004-07-23 |
2007-04-18 |
Genentech Inc |
Cristalizacion de anticuerpos o fragmentos de ellos.
|
TW200621282A
(en)
*
|
2004-08-13 |
2006-07-01 |
Wyeth Corp |
Stabilizing formulations
|
US20060051347A1
(en)
*
|
2004-09-09 |
2006-03-09 |
Winter Charles M |
Process for concentration of antibodies and therapeutic products thereof
|
US20060194301A1
(en)
*
|
2004-10-09 |
2006-08-31 |
Doctor Bhupendra P |
Large-scale production of human serum butyrylcholinesterase as a bioscavenger
|
JO3000B1
(ar)
*
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
EA016022B1
(ru)
*
|
2004-12-21 |
2012-01-30 |
Сентокор, Инк. |
Выделенное антитело млекопитающего против il-12 и способ изменения его активности
|
MX2007009091A
(es)
*
|
2005-01-28 |
2008-01-11 |
Wyeth Corp |
Formulaciones de polipeptido liquidas estabilizadas.
|
WO2006113666A2
(en)
*
|
2005-04-19 |
2006-10-26 |
Massachusetts Institute Of Technology |
Amphiphilic polymers and methods of use thereof
|
BRPI0611901A2
(pt)
*
|
2005-06-14 |
2012-08-28 |
Amgen, Inc |
composição, liofilizado, kit, e, processo para preparar uma composição
|
JP2009501006A
(ja)
*
|
2005-06-30 |
2009-01-15 |
セントカー・インコーポレーテツド |
抗il−23抗体、組成物、方法および用途
|
TW201444869A
(zh)
|
2005-06-30 |
2014-12-01 |
Abbvie Inc |
Il-12/p40結合蛋白
|
EP2264161A1
(en)
*
|
2005-07-02 |
2010-12-22 |
Arecor Limited |
Stable aqueous systems comprising proteins
|
MX2008000985A
(es)
*
|
2005-07-21 |
2008-04-07 |
Abbott Lab |
Expresion de gen multiple que incluye construcciones y metodos sorf (cuadro de lectura abierta simple) con poliproteinas, pro-proteinas y proteolisis.
|
EP1962907A2
(en)
*
|
2005-12-21 |
2008-09-03 |
Wyeth a Corporation of the State of Delaware |
Protein formulations with reduced viscosity and uses thereof
|
JP5231810B2
(ja)
|
2005-12-28 |
2013-07-10 |
中外製薬株式会社 |
抗体含有安定化製剤
|
US20080071063A1
(en)
*
|
2006-02-03 |
2008-03-20 |
Medimmune, Inc. |
Protein Formulations
|
US20070202051A1
(en)
*
|
2006-02-10 |
2007-08-30 |
Pari Gmbh |
Aerosols for sinunasal drug delivery
|
EP1987067A4
(en)
|
2006-02-15 |
2012-01-25 |
Imclone Llc |
ANTIBODY FORMULATION
|
DE102006030164A1
(de)
*
|
2006-06-29 |
2008-01-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Inhalative Pulver
|
TWI527603B
(zh)
*
|
2006-06-30 |
2016-04-01 |
艾伯維生物技術有限責任公司 |
自動注射裝置
|
GB0615312D0
(en)
|
2006-08-02 |
2006-09-13 |
Univ Dundee |
Protein Solubilisation
|
EP2087102B1
(en)
|
2006-10-13 |
2014-03-26 |
Janssen Biotech, Inc. |
Enhancement of hybridoma fusion efficiencies through cell synchronization
|
MX2009004351A
(es)
*
|
2006-10-27 |
2009-05-12 |
Abbott Biotech Ltd |
Anticuerpos anti-htnfalfa cristalinos.
|
KR20090086632A
(ko)
*
|
2006-12-06 |
2009-08-13 |
와이어쓰 |
만니톨을 함유하는 고단백질 농도 제형
|
CN104524567A
(zh)
*
|
2007-01-16 |
2015-04-22 |
阿布维公司 |
用于治疗银屑病的方法
|
MX2009008769A
(es)
*
|
2007-02-16 |
2009-08-25 |
Wyeth Corp |
Formulaciones de proteina que contienen sorbitol.
|
MX2009010361A
(es)
|
2007-03-29 |
2009-10-16 |
Abbott Lab |
Anticuerpos il-12 anti-humanos cristalinos.
|
AU2008248780B2
(en)
*
|
2007-05-02 |
2013-01-31 |
F. Hoffmann-La Roche Ag |
Method for stabilizing a protein
|
US8753839B2
(en)
*
|
2007-08-08 |
2014-06-17 |
Abbvie Inc. |
Compositions and methods for crystallizing antibodies
|
US8420081B2
(en)
*
|
2007-11-30 |
2013-04-16 |
Abbvie, Inc. |
Antibody formulations and methods of making same
|
JP6078217B2
(ja)
*
|
2008-01-15 |
2017-02-08 |
アッヴィ・ドイチュラント・ゲー・エム・ベー・ハー・ウント・コー・カー・ゲー |
粉末化されたタンパク質組成物及びその作製方法
|
MX2010008364A
(es)
*
|
2008-01-30 |
2010-08-23 |
Abbott Lab |
Composiciones y metodos para cristalizar fragmentos de anticuerpo.
|
TW201513883A
(zh)
*
|
2008-03-18 |
2015-04-16 |
Abbvie Inc |
治療牛皮癬的方法
|
US20100172862A1
(en)
*
|
2008-11-28 |
2010-07-08 |
Abbott Laboratories |
Stable antibody compositions and methods of stabilizing same
|
US8470308B2
(en)
|
2009-01-03 |
2013-06-25 |
Ray C. Wasielewski |
Enhanced medical implant comprising disrupted tooth pulp and tooth particles
|
MX2011011541A
(es)
*
|
2009-04-29 |
2012-02-28 |
Abbott Biotech Ltd |
Dispositivo de inyeccion automatico.
|
SG175188A1
(en)
*
|
2009-05-04 |
2011-11-28 |
Abbott Biotech Ltd |
Stable high protein concentration formulations of human anti-tnf-alpha-antibodies
|